These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7921682)

  • 1. [Routine vaccinations in children and adults infected with HIV].
    Dabis F; Lepage P; Msellati P; Van de Perre P; Nsengumuremyi F; Hitimana DG; Ladner J; Leroy V
    Sante; 1994; 4(3):173-82. PubMed ID: 7921682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus infection and routine childhood immunisation.
    von Reyn CF; Clements CJ; Mann JM
    Lancet; 1987 Sep; 2(8560):669-72. PubMed ID: 2887950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
    Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
    Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and routine childhood immunization: a review.
    Clements CJ; von Reyn CF; Mann JM
    Bull World Health Organ; 1987; 65(6):905-11. PubMed ID: 3325188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination status and sequence of vaccinations as risk factors for hospitalisation among outpatients in a high mortality country.
    Biai S; Rodrigues A; Nielsen J; Sodemann M; Aaby P
    Vaccine; 2011 May; 29(20):3662-9. PubMed ID: 21440640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Sep; 45(RR-12):1-35. PubMed ID: 8801442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization status of children born to human immunodeficiency virus (HIV)-infected mothers in two Texas cities.
    Schulte JM; Burkham S; Squires JE; Doran T; Hamaker DW; Pelosi J; Graper J; Davis R; Caldwell MB
    South Med J; 2000 Jan; 93(1):48-52. PubMed ID: 10653065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of the HIV-1 infected child.
    Madhi SA
    SADJ; 2001 Dec; 56(12):610-3. PubMed ID: 11887449
    [No Abstract]   [Full Text] [Related]  

  • 9. Early vaccinations are not risk factors for celiac disease.
    Myléus A; Stenlund H; Hernell O; Gothefors L; Hammarström ML; Persson LÅ; Ivarsson A
    Pediatrics; 2012 Jul; 130(1):e63-70. PubMed ID: 22732174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.
    Kovac M; Rathi N; Kuriyakose S; Hardt K; Schwarz TF
    Vaccine; 2015 May; 33(22):2594-601. PubMed ID: 25882172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-differential and non-specific effects of routine vaccinations in a rural area with low vaccination coverage: an observational study from Senegal.
    Aaby P; Nielsen J; Benn CS; Trape JF
    Trans R Soc Trop Med Hyg; 2015 Jan; 109(1):77-84. PubMed ID: 25573112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide control of disease through immunization. Progress and prospects.
    Hayden GF; Henderson RH
    Infect Dis Clin North Am; 1990 Jun; 4(2):245-58. PubMed ID: 2345289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.
    Daley MF; Yih WK; Glanz JM; Hambidge SJ; Narwaney KJ; Yin R; Li L; Nelson JC; Nordin JD; Klein NP; Jacobsen SJ; Weintraub E
    Vaccine; 2014 May; 32(25):3019-24. PubMed ID: 24699471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization in the Well Baby Clinic of Dr. Pirngadi Hospital Medan.
    Dalimunthe S; Tjipta GD; Lubis IZ; Manoeroeng SM; Lubis CP
    Paediatr Indones; 1990; 30(1-2):42-53. PubMed ID: 2284119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
    Dominicus R; Galtier F; Richard P; Baudin M
    Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adverse events following immunization: AEFI in 17 children between 0 and 2 years of age].
    Taraszkiewicz F; Bogus-Parafieniuk W; Ołdak E; Sulik A
    Przegl Epidemiol; 1994; 48(4):505-9. PubMed ID: 7597191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.